-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 14/10/25 )
NAV
₹118.88
Last change
₹-0.68 -0.01%
Fund Size (AUM)
8113.59 Cr
Performance
19.43% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 14/10/25
AUM
8113.59 Cr
Expense Ratio
1.8 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | -3.47% | 21.6% | 19.43% |
| BSE Healthcare TR INR | -2.62% | 22.66% | 16.82% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.29% |
Lupin Ltd |
7.26% |
Divi's Laboratories Ltd |
7.01% |
Cipla Ltd |
6.48% |
Apollo Hospitals Enterprise Ltd |
5.92% |
Dr Reddy's Laboratories Ltd |
5.91% |
Vijaya Diagnostic Centre Ltd |
3.56% |
Medplus Health Services Ltd |
3.39% |
Gland Pharma Ltd |
3.24% |
GlaxoSmithKline Pharmaceuticals Ltd |
2.99% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
19.97% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.28% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
18.88% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
18.88% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
17.29% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.22% (5Y)
-
